Comparing Treatment Options for Recurrence of Venous Thromboembolism in Cancer Patients: DOACs vs LMWH – Findings from an American Study

2023-06-29 06:00:00

Treatment with direct oral anticoagulants (DOACs) does not lead to recurrence of venous thromboembolism in patients with cancer more often than treatment with low molecular weight heparins (LMWH). This has emerged from an American study (JAMA Intern Med. 2023;329:1924-33).

Patients with cancer have a greatly increased risk of venous thromboembolism. LMWH are…

The entire content of this article is only accessible to subscribers.

Read 3 articles FREE

Make an account. Free and without obligation.

I want 3x free

Always access to all NTvG publications?

Subscribe today!

Take the introductory subscription

€ 32.95 for 12 weeks!

I want to meet

Do you already have a subscription? login